Kathleen Skarvan Sells 38,954 Shares of Electromed, Inc. (NYSE:ELMD) Stock

Electromed, Inc. (NYSE:ELMD) Director Kathleen Skarvan sold 38,954 shares of the company’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $29.28, for a total transaction of $1,140,573.12. Following the sale, the director now owns 32,622 shares in the company, valued at $955,172.16. This represents a 54.42 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Kathleen Skarvan also recently made the following trade(s):

• On Friday, February 14th, Kathleen Skarvan sold 8,640 shares of Electromed stock. The stock was sold at an average price of $32.25, for a total transaction of $278,640.00.

Electromed Stock Performance

Electromed stock traded down $0.19 during midday trading on Wednesday, hitting $29.36. 96,902 shares of the company were exchanged, compared to its average volume of 107,469. The business has a fifty day simple moving average of $31.40 and a two-hundred day simple moving average of $25.15. Electromed, Inc. has a fifty-two week low of $13.74 and a fifty-two week high of $35.56. The firm has a market capitalization of $251.32 million, a PE ratio of 39.15 and a beta of 0.33.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Electromed from a “strong-buy” rating to a “buy” rating in a research note on Wednesday.

Institutional Trading of Electromed

Institutional investors have recently modified their holdings of the stock. Russell Investments Group Ltd. acquired a new stake in shares of Electromed during the 4th quarter worth approximately $37,000. IFP Advisors Inc purchased a new stake in shares of Electromed during the fourth quarter worth approximately $59,000. Quantbot Technologies LP acquired a new position in shares of Electromed during the fourth quarter worth $99,000. Bank of America Corp DE increased its holdings in shares of Electromed by 179.2% in the 4th quarter. Bank of America Corp DE now owns 4,004 shares of the company’s stock valued at $118,000 after acquiring an additional 2,570 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Electromed in the 4th quarter valued at $119,000. Institutional investors and hedge funds own 40.82% of the company’s stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.